Report-store Details

  • Home
  • Report-store Details
Contact Us
+1 (732) 526 1166
India: 040-46013143

info@sciinovgroup.com

Email Us

Report Type: Industry Trends
Report Category: Regulatory Insights
Report Subcategory: Orphan Drug Designation
Price: 2999.00
Date: February 2022

Orphan Drug Designation (ODD): Drugs, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, Manufacturing

Orphan Drug Designation (ODD) provides market exclusivity for the rare indication drugs. ODD criteria varies by country.

Regulatory authorities provides ODD are US FDA, Europe EMEA,Japan PMDA, China NMPA, Australia TGA, South Korea KFDA, Brazil ANVISA, Mexico COFEPRIS, France ANSM, Spain AEMPS and etc.

Have a business Query? Let's Talk.

Email : info@sciinovgroup.com or Call : +1 (732) 526 1166
India: 040-46013143

Get The Latest Updates

Signup For Newsletter

(c) 2021 Sciinov Group - All rights reserved.